WeVote

Bill

Bill

LD 1847

An Act To Institute Testing And Tracking Of Medical Use Cannabis And Cannabis Products Similar To Adult Use Cannabis And Cannabis Products, Dedicate A Portion Of The Adult Use Cannabis Sales And Excise Tax To Medical Use Cannabis Programs And Create A Study Group

132nd Legislature (2025-2026) Introduced by Sean Faircloth and 9 co-sponsors

Requires testing and tracking of medical cannabis like adult-use, dedicates part of adult-use tax receipts to fund medical programs, and forms a study group.

Died in Possession of the Senate when the Legislature adjourned Sine Die and was PLACED IN THE LEGISLATIVE FILES. (DEAD)
0
WeVote Research Nonpartisan
Bill Summary · LD 1847

Summary of LD 1847

Overview

LD 1847, titled “An Act To Institute Testing And Tracking Of Medical Use Cannabis And Cannabis Products Similar To Adult Use Cannabis And Cannabis Products, Dedicate A Portion Of The Adult Use Cannabis Sales And Excise Tax To Medical Use Cannabis Programs And Create A Study Group,” proposes regulatory enhancements for medical cannabis and a dedicated funding mechanism, along with a study group to review program design and funding.

  • Introduced: April 30, 2025
  • Status: Carried over to a future session (special or regular) of the 132nd Legislature under Joint Order SP 800
  • Committee: Referred to the Committee on Veterans and Legal Affairs (action included: suggested and ordered printed; concurrence sent; later work session tabled)
  • Legislative actions to date:
    • 2025-04-30: Referred to Veterans and Legal Affairs
    • 2025-05-16: Work Session Held – Tabled
    • 2025-05-19: Carry Over Requested; Carry Over Approved
    • 2025-06-25: Carried over in the same posture to any session per SP 800

Purpose and intent

  • Create a testing and tracking framework for medical-use cannabis and cannabis products that mirrors, or is similar to, the system used for adult-use cannabis and products.
  • Establish a mechanism to allocate a portion of adult-use cannabis sales and excise tax revenue to support medical-use cannabis programs.
  • Establish a study group to examine the medical-use cannabis program structure, implementation, and funding implications.

Key provisions (conceptual)

  • Testing requirements: Mandate standardized testing for medical-use cannabis and related products to ensure safety, potency, and quality.
  • Tracking system: Implement or require a seed-to-sale tracking or comparable regulatory tracking mechanism for medical-use cannabis products.
  • Revenue allocation: Dedicate a portion of adult-use cannabis sales and excise tax revenue to fund medical-use cannabis programs and activities.
  • Study group: Create a study group to analyze program design, funding needs, effectiveness, and potential reforms; convene, report findings, and guide future legislative action.

Who would be affected

  • Medical cannabis patients and providers/distributors meeting medical-use categories
  • Licensed medical cannabis facilities (growers, processors, dispensaries) subject to testing and tracking requirements
  • State regulatory bodies overseeing cannabis (regulatory agencies, public health, law enforcement)
  • Taxpayers and participants in the adult-use cannabis market (through revenue allocations)
  • Stakeholders involved in medical cannabis policy, access, and funding

Implementation considerations and timeline

  • As presently configured, the bill would require regulatory rulemaking and establishment of testing and tracking provisions if enacted.
  • Revenue provisions would require mechanisms for dedicating a share of adult-use tax receipts to medical programs, subject to legislative appropriation and annual budgeting processes.
  • The study group would likely be formed promptly upon enactment or agreement, with a report to follow.

Status and next steps

  • Because the bill is carried over, it has not progressed to enactment in the current session.
  • It may be reintroduced or carried into a later session of the 132nd Legislature, potentially with amendments based on study group findings or stakeholder input.
  • Interested readers should monitor updates from the Joint Orders SP 800 and the Veterans and Legal Affairs committee for further action, amendments, or reports.

If you’d like, I can add a side-by-side comparison with existing medical and adult-use cannabis provisions in the state to highlight potential changes LD 1847 would introduce.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.